PT-401

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePT-401
Drug Alias NameEpo-Epo dimer (DNAPrint)Epo-Epo dimer (Beth Israel)erythropoietin dimer (DNAPrint)erythropoietin dimer (Beth Israel)PT-401
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsImmune System DiseasesAnemiaHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBeth Israel Deaconess Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeth Israel Deaconess Medical CenterDNAPrint Genomics Inc
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesAnemiaHematologic Diseases

Other Information

ATC CodeN/A
Related LinksN/A